Format

Send to

Choose Destination
Immunol Today. 1993 Jun;14(6):326-32.

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.

Author information

1
Dept of Surgery, University of Pittsburgh Health Science Center, PA 15213.

Erratum in

  • Immunol Today. 2008 Apr;29(4):149.

Abstract

One line of thought in organ transplantation feels that immunosuppressive drugs can lead to tolerance induction by allowing a previously unrecognized common mechanism of cell migration and microchimerism to occur, persist, and in some cases, become drug independent. It has been recognized that there is a spectrum of susceptibility of different organs to cellular rejection and that the variable ability of these organs to induce donor-specific nonreactivity reflects their comparative content of migratory leukocytes. Here, Thomas Starzl and colleagues discuss how many of the enigmas of transplantation immunology can be explained by this chimerism.

PMID:
8397774
PMCID:
PMC2979321
DOI:
10.1016/0167-5699(93)90054-o
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center